IFNA1 and systemic lupus erythematosus: The newest development indicates that targeting pDCs, for depletion or to inhibit cytokine production, in SLE is a more specific way to interfere with the positive feed-back loop of IFNα production and signaling, in addition to eliminating the cytokines that support autoantibody-secreting plasma cells.